Seattle startup with fresh approach to Parkinson’s and Alzheimer’s disease raises $96M by Charlotte Schubert on November 29, 2022November 29, 2022 at 9:46 am Cajal Neuroscience, a Seattle startup taking a unique approach to developing treatments for neurodegenerative diseases like Alzheimer’s and Parkinson’s, revealed more details about its strategy and announced $96 million in… Read More